Error loading player: No playable sources found
2215
Clinical Advances in Steatotis Liver Disease and MASH
Date
May 18, 2024
SOCIETY: AGA Newer and novel tools in understanding and management of patients with MASLD
Presentations:
| LEAN VETERANS WITH MASLD HAVE SIGNIFICANTLY GREATER RISK OF CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY COMPARED TO OVERWEIGHT/OBESE VETERANS WITH MASLD |
| PARENTAL OBESITY AT PREGNANCY WITH RISK OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN YOUNG ADULT OFFSPRING |
| (WITHDRAWN) ALTERATION OF GUT MICROBIOME AND METABOLITES IN WILSON’S DISEASE |
| IMPACT OF BARIATRIC SURGERY ON HOSPITAL OUTCOMES IN PATIENTS ADMITTED WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A 2020 RETROSPECTIVE ANALYSIS IN THE UNITED STATES |
| STATIN THERAPY AND IMPROVED WAITLIST OUTCOMES IN LIVER TANS PANT CANDIDATES WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS (MASH) CIRRHOSIS |
| THE CONTINUED ALARMING RISE IN RATES OF ALCOHOL ASSOCIATED HEPATITIS AMONG U.S. VETERANS PERSISTS BEYOND THE COVID-19 PANDEMIC |
Moderators
Beth Israel Deaconess Medical Center
Virginia Commonwealth Univ.
Speakers
Tracks
Related Products
RACIAL AND ETHNIC DISPARITIES IN THE LONG-TERM INCIDENCE OF CIRRHOSIS IN A NATIONAL COHORT OF VETERANS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE
BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
Portal Hypertension: Advances in Management of Disease
SOCIETY: AGA Updates and newer management strategies for portal hypertension in patients with liver disease…
